Phytochemical Profiling And Antioxidant Potential Of Calendula Officinalis: A Pharmacognostic And Biotechnological Perspective
DOI:
https://doi.org/10.66220/3zancg55Keywords:
Calendula officinalis, Pot Marigold, Pharmacognosy, Phytochemical Profiling, Antioxidant Potential, Plant Biotechnology, Quality Control, Herbal Drug DevelopmentAbstract
Calendula officinalis L. (Pot Marigold), a medicinal plant belonging to the family Asteraceae, has been widely used in traditional medicine because of its diverse therapeutic properties. Owing to its rich phytochemical composition and broad pharmacological potential, it has attracted increasing attention in herbal drug development, nutraceuticals, cosmeceuticals, and pharmaceutical biotechnology. This review aims to provide a comprehensive overview of the pharmacognostic characteristics, phytochemical profile, antioxidant potential, and biotechnological significance of C. officinalis. Relevant published literature on the pharmacognosy, phytochemistry, antioxidant activity, and medicinal plant biotechnology of C. officinalis was critically reviewed and synthesized. Information on pharmacognostic evaluation, phytochemical characterization, in vitro antioxidant assays, and biotechnological approaches was compiled and analyzed. The review indicates that C. officinalis is rich in flavonoids, phenolic compounds, carotenoids, triterpenoids, essential oils, and other bioactive metabolites responsible for its therapeutic activities. Antioxidant potential has been consistently demonstrated through assays such as DPPH radical scavenging, total phenolic content (TPC), and total flavonoid content (TFC), highlighting its ability to scavenge free radicals and regulate oxidative stress. Furthermore, pharmacognostic evaluation supports its authentication and quality assessment, while advances in plant tissue culture, metabolic engineering, and bioactive compound optimization enhance its sustainable utilization. Calendula officinalis represents a valuable natural source of antioxidants and bioactive compounds with significant potential for modern healthcare applications. Integrating pharmacognostic evaluation with biotechnological innovations can facilitate the development of standardized, effective, and sustainable herbal formulations while supporting future pharmaceutical and therapeutic applications.
Downloads
References
1. Atanasov AG, Zotchev SB, Dirsch VM, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200-16. doi: 10.1038/s41573-020-00114-z.
2. Efstratiou E, Hussain AI, Nigam PS, Moore JE, Ayub MA, Rao JR. Antimicrobial activity of Calendula officinalis petal extracts against fungi, as well as Gram-negative and Gram-positive clinical pathogens. Complement Ther Clin Pract. 2012;18(3):173-6. doi: 10.1016/j.ctcp.2012.02.003.
3. Arora D, Rani A, Sharma A. A review on phytochemistry and ethnopharmacological aspects of Calendula officinalis. Pharmacogn Rev. 2013;7(14):179-87. doi: 10.4103/0973-7847.120520.
4. Miguel MG. Antioxidant and anti-inflammatory activities of essential oils: a short review. Molecules. 2010;15(12):9252-87. doi: 10.3390/molecules15129252.
5. Ramawat KG, Merillon JM. Biotechnology of Medicinal Plants: Vitalizer and Therapeutic Applications. Science Publishers; 2007.
6. Pommier P, Gomez F, Sunyach MP, et al. Phase III randomized trial of Calendula officinalis compared with trolamine for prevention of acute dermatitis during irradiation. J Clin Oncol. 2004;22(8):1447-53. doi: 10.1200/jco.2004.07.063.
7. Muley BP, Khadabadi SS, Banarase NB. Phytochemical constituents and pharmacological activities of Calendula officinalis: A review. Trop J Pharm Res. 2009;8(5):455-65. doi: 10.4314/tjpr.v8i5.48090.
8. Singleton VL, Orthofer R, Lamuela-Raventós RM. Analysis of total phenols and other oxidation substrates and antioxidants by means of Folin–Ciocalteu reagent. Methods Enzymol. 1999;299:152-78. doi: 10.1016/S0076-6879(99)99017-1.
9. Zhishen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem. 1999;64(4):555-9. doi: 10.1016/S0308-8146(98)00102-2.
10. Ukiya M, Akihisa T, Yasukawa K, et al. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of Calendula officinalis flowers. J Nat Prod. 2006;69(12):1692-6. doi: 10.1021/np068016b.
11. Neukirch H, D’Ambrosio M, Sosa S, Altinier G, Della Loggia R, Guerriero A. Improved anti-inflammatory activity of three new terpenoids derived, by systematic chemical modifications, from the abundant triterpenes of the flowery plant Calendula officinalis. Chem Biodivers. 2005;2(5):657-71. doi: 10.1002/cbdv.200590042.
12. Gazim ZC, Rezende CM, Fraga SR, Svidzinski TIE, Cortez DAG. Antifungal activity of the essential oil from Calendula officinalis L. (Asteraceae) growing in Brazil. Braz J Microbiol. 2008;39(1):61-3. doi: 10.1590/S1517-838220080001000015.
13. Halliwell B. Free radicals and antioxidants: updating a personal view. Nutr Rev. 2012;70(5):257-65. doi: 10.1111/j.1753-4887.2012.00476.x.
14. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med. 1996;20(7):933-56. doi: 10.1016/0891-5849(95)02227-9.
15. Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. LWT Food Sci Technol. 1995;28(1):25-30. doi: 10.1016/S0023-6438(95)80008-5.
16. Prior RL, Wu X, Schaich K. Standardized methods for the determination of antioxidant capacity and phenolics in foods and dietary supplements. J Agric Food Chem. 2005;53(10):4290-302. doi: 10.1021/jf0502698.
17. Della Loggia R, Tubaro A, Sosa S, et al. The role of flavonoids and triterpenoids in the anti-inflammatory activity of Calendula officinalis. Fitoterapia. 1994;65:475-81. doi: 10.1055/s-2006-959562.
18. Evans WC. Trease and Evans Pharmacognosy. 16th ed. Elsevier; 2009. doi: 10.1016/B978-0-7020-2933-2.X0001-9.
19. World Health Organization. Quality Control Methods for Herbal Materials. WHO Press; 2011.
20. Murashige T, Skoog F. A revised medium for rapid growth and bio assays with tobacco tissue cultures. Physiol Plant. 1962;15(3):473-97. doi: 10.1111/j.1399-3054.1962.tb08052.x.
21. Verpoorte R, Contin A, Memelink J. Biotechnology for the production of plant secondary metabolites. Phytochem Rev. 2002;1(1):13-25. doi: 10.1023/A:1015871916833.
22. Joshi K, Chavan P, Warude D, Patwardhan B. Molecular markers in herbal drug technology. Curr Sci. 2004;87(2):159-65.
23. Rates SMK. Plants as source of drugs. Toxicon. 2001;39(5):603-13. doi: 10.1016/S0041-0101(00)00154-9.
24. Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol. 2014;4:177. doi: 10.3389/fphar.2013.00177.
25. World Health Organization. WHO Guidelines on Good Agricultural and Collection Practices (GACP) for Medicinal Plants. Geneva: WHO; 2003.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Vashvi Kumar Sahu, Vicky Soni (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
In submitting an article to the Journal of PhytoPharmaceutical and Advanced Chemistry (JPPAC) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JPPAC are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
- I, and all co-authors, agree that, if the article is editorially accepted for publication in the Journal of PhytoPharmaceutical and Advanced Chemistry (JPPAC) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.
